117 related articles for article (PubMed ID: 17117944)
1. Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Couto M; Conceição I; de Carvalho M
J Peripher Nerv Syst; 2006 Dec; 11(4):353-4. PubMed ID: 17117944
[No Abstract] [Full Text] [Related]
2. Interferon-induced sarcoidosis.
Doyle MK; Berggren R; Magnus JH
J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
[TBL] [Abstract][Full Text] [Related]
3. Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
Scheler M; Proelss J; Bräuninger W; Bieber T; Wenzel J
Dermatology; 2007; 215(3):236-9. PubMed ID: 17823522
[TBL] [Abstract][Full Text] [Related]
4. Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.
Höftberger R; Garzuly F; Dienes HP; Grubits J; Rohonyi B; Fischer G; Hanzely Z; Lassmann H; Budka H
Mult Scler; 2007 Nov; 13(9):1100-6. PubMed ID: 17967838
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C: be positively aware of the risk of transmission and treatment.
Johnson B
Posit Aware; 2002; 13(6):29-31. PubMed ID: 12484333
[No Abstract] [Full Text] [Related]
6. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.
Marzo ME; Tintoré M; Fabregues O; Montalbán X; Codina A
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):604. PubMed ID: 9771799
[No Abstract] [Full Text] [Related]
7. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
Shinohara MM; Davis C; Olerud J
J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
[TBL] [Abstract][Full Text] [Related]
8. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment.
Dyck PJ; O'Brien PC; Oviatt KF; Dinapoli RP; Daube JR; Bartleson JD; Mokri B; Swift T; Low PA; Windebank AJ
Ann Neurol; 1982 Feb; 11(2):136-41. PubMed ID: 7041788
[TBL] [Abstract][Full Text] [Related]
9. Prednisone-responsive hereditary motor and sensory neuropathy.
Dyck PJ; Swanson CJ; Low PA; Bartleson JD; Lambert EH
Mayo Clin Proc; 1982 Apr; 57(4):239-46. PubMed ID: 7070119
[TBL] [Abstract][Full Text] [Related]
10. Reversible multifocal conduction block in sarcoid neuropathy.
Suzuki C; Tomiyama M; Baba M; Jinichi N; Ogawa M; Kurahashi K; Kamijo M
J Peripher Nerv Syst; 2006 Mar; 11(1):93-5. PubMed ID: 16519790
[No Abstract] [Full Text] [Related]
11. Steroid-responsive multifocal demyelinating neuropathy with central involvement.
Liguori R; Rizzi R; Vetrugno R; Salvi F; Lugaresi A; Cevoli S; Montagna P
Muscle Nerve; 1999 Feb; 22(2):262-5. PubMed ID: 10024141
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha associated arthritis.
Chung A; Older SA
J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
[TBL] [Abstract][Full Text] [Related]
13. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
14. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
[No Abstract] [Full Text] [Related]
15. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C, interferon alfa, and depression.
Zdilar D; Franco-Bronson K; Buchler N; Locala JA; Younossi ZM
Hepatology; 2000 Jun; 31(6):1207-11. PubMed ID: 10827143
[No Abstract] [Full Text] [Related]
17. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammatory demyelinating polyneuropathy following treatment with peglated interferon α-2a for chronic hepatitis C virus infection.
Ying C; Xue-Mei H; Yao G; Song-Yan L
Neurol India; 2011; 59(1):141-2. PubMed ID: 21339691
[No Abstract] [Full Text] [Related]
19. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
[No Abstract] [Full Text] [Related]
20. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
Fontana M; Ciuffreda D; Moradpour D; Pascual M
Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
